Charles River Laboratories CRL Manufacturing — Operating Income (Loss)
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's manufacturing — operating income (loss).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Charles River Laboratories's manufacturing — operating income (loss)?
- Charles River Laboratories (CRL) reported manufacturing — operating income (loss) of $46.84M in Q1 2026.
- How has Charles River Laboratories's manufacturing — operating income (loss) changed year-over-year?
- Charles River Laboratories's manufacturing — operating income (loss) increased by 643.4% year-over-year, from -$8.62M to $46.84M.
- What is the long-term trend for Charles River Laboratories's manufacturing — operating income (loss)?
- Over 2 years (2023 to 2025), Charles River Laboratories's manufacturing — operating income (loss) has grown at a 44.4% compound annual growth rate (CAGR), from $88.33M to -$184.28M.
- What does manufacturing — operating income (loss) mean?
- The profit or loss generated by the manufacturing segment from its core business operations.
- How do you interpret manufacturing — operating income (loss)?
- An increase signifies improved operational profitability and effective cost control within the segment.
- How does manufacturing — operating income (loss) compare across companies?
- Standard operating profit metric used to compare segment performance across peer companies.